A thin phenotype is protective for impaired glucose tolerance and related to low birth weight in mice

Marcelino Hernandez-Valencia1, Mary-Elizabeth Patti

  • 1Endocrine Research Unit, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. mhernandezvalencia@prodigy.net.mx

Archives of Medical Research
|September 15, 2006
PubMed

Insights

Postnatal nutritional modification can prevent impaired glucose tolerance (IGT) in low-birth-weight mice. Restricting early postnatal weight gain protected offspring from developing IGT and diabetes later in life.

Area of Science:

  • Metabolic health
  • Developmental programming
  • Nutritional science

Background:

  • Low birth weight is a significant risk factor for impaired glucose tolerance (IGT) and type 2 diabetes in adulthood.
  • This risk is observed in both preterm and term infants, highlighting the long-term consequences of early life conditions.
  • Improved neonatal care increases survival rates of low-birth-weight infants, making preventative strategies crucial.

Purpose of the Study:

  • To investigate the efficacy of postnatal nutritional modification in preventing low-birth-weight-associated glucose intolerance.
  • To determine if preventing early postnatal weight gain can mitigate the risk of developing IGT and diabetes.
  • To utilize a mouse model simulating maternal undernutrition during late pregnancy.

Main Methods:

  • Three groups of mouse offspring were studied: controls (C), undernutrition with low birth weight (UN) fed ad libitum, and undernutrition with continued postnatal food restriction (UN-UN).
  • Maternal undernutrition during the third week of pregnancy resulted in significantly reduced birth weights in UN and UN-UN groups compared to controls.
  • Postnatal nutritional status was manipulated, with the UN group allowed to catch up on growth while the UN-UN group experienced continued caloric restriction.

Main Results:

  • While initial birth weights were reduced, body weights were similar until 4 months. The UN-UN group showed reduced body weight at 6 months.
  • Glucose tolerance, insulin tolerance, and glucose-stimulated insulin secretion were comparable among all groups at 2 months.
  • By 6 months, UN mice developed IGT, whereas UN-UN mice were protected, showing glucose levels similar to controls, potentially due to improved insulin sensitivity.

Conclusions:

  • Early postnatal nutritional interventions, specifically preventing rapid weight gain, are associated with the prevention of IGT in low-birth-weight individuals.
  • Altering early nutrition can be a viable strategy to mitigate the long-term metabolic risks associated with low birth weight.
  • These findings in a mouse model provide a basis for exploring similar interventions in human infants at risk.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...